Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionmonoacylglycerol lipase activity

ABHD15 ABHD16B

1.25e-0416212GO:0047372
GeneOntologyMolecularFunctionmannosyltransferase activity

ALG8 ALG9

3.92e-0428212GO:0000030
GeneOntologyMolecularFunctionphosphatidylinositol 3-kinase binding

GSN INSR

9.27e-0443212GO:0043548
GeneOntologyMolecularFunctiontransmembrane signaling receptor activity

NPC1 AVPR1B IL7R DRD5 GRIN2D INSR

2.14e-031353216GO:0004888
GeneOntologyMolecularFunctionpostsynaptic neurotransmitter receptor activity

DRD5 GRIN2D

2.79e-0375212GO:0098960
GeneOntologyMolecularFunctioncysteine-type endopeptidase activity

USP6 TINAG

3.65e-0386212GO:0004197
GeneOntologyMolecularFunctionneurotransmitter receptor activity

DRD5 GRIN2D

4.90e-03100212GO:0030594
GeneOntologyMolecularFunctionlipase activity

ABHD15 ABHD16B

9.14e-03138212GO:0016298
GeneOntologyBiologicalProcessregulation of systemic arterial blood pressure by vasopressin

AVPR1B DRD5

8.92e-065202GO:0001992
GeneOntologyBiologicalProcesssymbiont entry into host cell

NPC1 AVPR1B GSN INSR

1.90e-05169204GO:0046718
GeneOntologyBiologicalProcesssymbiont entry into host

NPC1 AVPR1B GSN INSR

2.23e-05176204GO:0044409
GeneOntologyBiologicalProcessbiological process involved in interaction with host

NPC1 AVPR1B GSN INSR

6.13e-05228204GO:0051701
GeneOntologyBiologicalProcessdolichol-linked oligosaccharide biosynthetic process

ALG8 ALG9

2.04e-0422202GO:0006488
GeneOntologyBiologicalProcessdolichol metabolic process

ALG8 ALG9

2.43e-0424202GO:0019348
GeneOntologyBiologicalProcessviral life cycle

NPC1 AVPR1B GSN INSR

2.85e-04340204GO:0019058
GeneOntologyBiologicalProcessbiological process involved in symbiotic interaction

NPC1 AVPR1B GSN INSR

3.22e-04351204GO:0044403
GeneOntologyBiologicalProcessglycoprotein biosynthetic process

NPC1 ALG8 ALG9 INSR

3.43e-04357204GO:0009101
GeneOntologyBiologicalProcessmembrane raft organization

NPC1 GSN

3.57e-0429202GO:0031579
GeneOntologyBiologicalProcesspolyprenol metabolic process

ALG8 ALG9

3.57e-0429202GO:0016093
GeneOntologyBiologicalProcessalcohol metabolic process

NPC1 AVPR1B ALG8 ALG9

5.90e-04412204GO:0006066
GeneOntologyBiologicalProcessglycoprotein metabolic process

NPC1 ALG8 ALG9 INSR

6.92e-04430204GO:0009100
GeneOntologyBiologicalProcessviral process

NPC1 AVPR1B GSN INSR

9.20e-04464204GO:0016032
GeneOntologyCellularComponentlumenal side of endoplasmic reticulum membrane

ALG8 ALG9

5.61e-0435212GO:0098553
GeneOntologyCellularComponentpostsynaptic density

PRICKLE2 USP6 DRD5 GRIN2D

9.56e-04451214GO:0014069
GeneOntologyCellularComponentlumenal side of membrane

ALG8 ALG9

1.05e-0348212GO:0098576
GeneOntologyCellularComponentasymmetric synapse

PRICKLE2 USP6 DRD5 GRIN2D

1.18e-03477214GO:0032279
GeneOntologyCellularComponentpostsynaptic specialization

PRICKLE2 USP6 DRD5 GRIN2D

1.43e-03503214GO:0099572
GeneOntologyCellularComponentside of membrane

ALG8 ALG9 HID1 IL7R INSR

1.48e-03875215GO:0098552
GeneOntologyCellularComponentneuron to neuron synapse

PRICKLE2 USP6 DRD5 GRIN2D

1.65e-03523214GO:0098984
GeneOntologyCellularComponentnuclear envelope

NPC1 PRICKLE2 MACO1 INSR

2.12e-03560214GO:0005635
HumanPhenoNeonatal sepsis

G6PC3 IL7R

2.54e-054112HP:0040187
Domain-

ABHD15 ABHD16B

7.81e-031192123.40.50.1820
DomainAB_hydrolase

ABHD15 ABHD16B

7.81e-03119212IPR029058
Domainfn3

IL7R INSR

1.41e-02162212PF00041
DomainFN3

IL7R INSR

2.08e-02199212PS50853
DomainFN3_dom

IL7R INSR

2.28e-02209212IPR003961
PathwayREACTOME_DISEASES_ASSOCIATED_WITH_N_GLYCOSYLATION_OF_PROTEINS

ALG8 ALG9

1.72e-0420142M27274
PathwayWP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS

ALG8 ALG9

2.71e-0425142M39813
Pubmed

Loss of NPC1 function in a patient with a co-inherited novel insulin receptor mutation does not grossly modify the severity of the associated insulin resistance.

NPC1 INSR

3.47e-07221220521171
Pubmed

Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive.

AVPR1B DRD5

3.47e-06521212486173
Pubmed

Localization of the murine Niemann-Pick C1 protein to two distinct intracellular compartments.

NPC1 G6PC3

7.28e-06721210787428
Pubmed

Congenital Disorders of N-Linked Glycosylation and Multiple Pathway Overview

ALG8 ALG9

3.24e-044421220301507
Pubmed

A large-scale candidate gene association study of age at menarche and age at natural menopause.

GDF11 DRD5 INSR

5.85e-0427521320734064
GeneFamilyAbhydrolase domain containing

ABHD15 ABHD16B

1.27e-04221424
GeneFamilyFibronectin type III domain containing

IL7R INSR

6.60e-03160142555
GeneFamilyADAM metallopeptidase domain containing|CD molecules

IL7R INSR

3.63e-02394142471
CoexpressionAtlasalpha beta T cells, T.4SP24int.Th, 4+ 8- TCRhi 24int, Thymus, avg-3

RUNDC3B GDF11 GSN IL7R

2.59e-04324214GSM399373_500
CoexpressionAtlasalpha beta T cells, T.8Mem.LN, CD8 TCRb CD44high CD122high, Lymph Node, avg-3

RUNDC3B GDF11 HID1 IL7R

2.75e-04329214GSM538395_500
CoexpressionAtlasalpha beta T cells, T.8Nve.LN, 4- 8+ 25- 62Lhi 44lo, Lymph Node, avg-3

RUNDC3B ABHD15 HID1 IL7R

2.91e-04334214GSM538406_500
CoexpressionAtlasalpha beta T cells, T.8SP24-.Th, 4- 8+ TCRhi 24-/lo, Thymus, avg-3

RUNDC3B ABHD15 HID1 IL7R

3.52e-04351214GSM399379_500
CoexpressionAtlasCD positive, CD4 Test NA, 4+8-B220-, Spleen, avg-1

RUNDC3B GDF11 HID1 IL7R

3.75e-04357214GSM403986_500
CoexpressionAtlasalpha beta T cells, T.8Eff.Sp.OT1.d15.VSVOva, CD8+ CD45.1+, Spleen, avg-2

RUNDC3B GDF11 HID1 IL7R

3.91e-04361214GSM538385_500
CoexpressionAtlasalpha beta T cells, T.8Mem.Sp.OT1.d100.LisOva, CD8+ CD45.1+, Spleen, avg-3

RUNDC3B GDF11 HID1 IL7R

4.08e-04365214GSM605904_500
CoexpressionAtlasalpha beta T cells, T.4SP69+.Th, 4+ 8- TCRhi 69+, Thymus, avg-3

RUNDC3B GDF11 GSN IL7R

4.08e-04365214GSM399376_500
CoexpressionAtlasalpha beta T cells, T.8Mem.Sp.OT1.d106.VSVOva, CD8+ CD45.1+, Spleen, avg-2

RUNDC3B GDF11 HID1 IL7R

4.16e-04367214GSM538401_500
CoexpressionAtlasgamma delta T cells, Tgd.vg2-.act.Sp, TCRd+ Vg2- CD44+, Spleen, avg-3

RUNDC3B GDF11 HID1 IL7R

4.61e-04377214GSM476681_500
CoexpressionAtlasgamma delta T cells, Tgd.vg2-.Sp, TCRd+ Vg2- CD44-, Spleen, avg-3

RUNDC3B GDF11 HID1 IL7R

4.84e-04382214GSM476684_500
CoexpressionAtlasalpha beta T cells, T.8Mem.Sp.OT1.d45.LisOva, CD8+ CD45.1+, Spleen, avg-2

RUNDC3B GDF11 HID1 IL7R

4.89e-04383214GSM605907_500
CoexpressionAtlasalpha beta T cells, T.8Mem.Sp.OT1.d45.VSVOva, CD8+ CD45.1+, Spleen, avg-3

RUNDC3B GDF11 HID1 IL7R

4.89e-04383214GSM538403_500
CoexpressionAtlasgamma delta T cells, Tgd.vg2+.Sp.TCRbko, TCRd+ Vg2+ CD44-, Spleen, avg-3

RUNDC3B GDF11 HID1 IL7R

5.14e-04388214GSM605790_500
CoexpressionAtlasgamma delta T cells, Tgd.Sp, TCRd+ CD3e+, Spleen, avg-3

RUNDC3B GDF11 HID1 IL7R

5.39e-04393214GSM476672_500
CoexpressionAtlasgamma delta T cells, Tgd.vg2+.act.Sp, TCRd+ Vg2+ CD44+, Spleen, avg-3

RUNDC3B GDF11 HID1 IL7R

5.49e-04395214GSM476678_500
CoexpressionAtlasgamma delta T cells, Tgd.vg2-24ahi.Th.TCRbko, TCRd+ Vg2- CD24+, Thymus, avg-3

RUNDC3B GDF11 HID1 IL7R

5.54e-04396214GSM605799_500
CoexpressionAtlasgamma delta T cells, Tgd.vg2-.Sp.TCRbko, TCRd+ Vg2- CD44-, Spleen, avg-3

RUNDC3B GDF11 HID1 IL7R

6.03e-04405214GSM605796_500
CoexpressionAtlasPlasmacytoid, DC.pDC.8+.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3

NPC1 ABHD15 GSN IL7R

6.26e-04409214GSM605840_500
CoexpressionAtlasPlasmacytoid, DC.pDC.8+.MLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-2

NPC1 ABHD15 GSN IL7R

6.32e-04410214GSM854297_500
CoexpressionAtlasPlasmacytoid, DC.pDC.8-.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3

NPC1 ABHD15 GSN IL7R

6.43e-04412214GSM605843_500
CoexpressionAtlasPlasmacytoid, DC.pDC.8+.SLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-3

NPC1 ABHD15 GSN IL7R

6.61e-04415214GSM854299_500
ToppCellmLN-ILC|mLN / Region, Cell class and subclass

ABHD15 GSN IL7R INSR

2.10e-06199214d6c299312c747fb1b7c53644c53efc03a5fffe85
ToppCellmLN-(3)_ILC|mLN / shred on region, Cell_type, and subtype

ABHD15 GSN IL7R INSR

2.10e-0619921400e0e2a766dd9c4d0a65f53d88fa50df4b6a3d60
ToppCellmLN-(3)_ILC-(30)_ILC|mLN / shred on region, Cell_type, and subtype

ABHD15 GSN IL7R INSR

2.10e-0619921433ac6d77099076df01299be429f4ba96f2f34cc1
ToppCellmLN-ILC-ILC|mLN / Region, Cell class and subclass

ABHD15 GSN IL7R INSR

2.10e-06199214ab09a06cdea2597e9fe4b4b304655e9de4d433f6
ToppCellCOVID_vent-Lymphocytic-T_cell-Gamma_Delta_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass

RUNDC3B IL7R DRD5

3.16e-05132213dbc0a332fd8f63ebdcf9716e45d7f46f26509349
ToppCellsevere_COVID-19-CD8+_T_naive|World / disease group, cell group and cell class (v2)

HID1 IL7R TMEM212

4.90e-05153213422483445af49c277fc8962d76a46ffafd872422
ToppCelldroplet-Lung-30m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RUNDC3B IL7R GRIN2D

6.59e-051692131de3ae36d3b60e961bfd9f7bdc37867b82a0417f
ToppCellCOVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass

NPC1 ABHD15 GSN

6.82e-05171213779c951d274ecbd1d546ac425d6c8e718623be5a
ToppCellCOVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass

NPC1 ABHD15 GSN

6.82e-05171213debbb071d260639b16269c94d172766908325c58
ToppCelldroplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NPC1 ABHD15 GSN

6.94e-0517221330916a902c151907745756d14327e24adc34afef
ToppCellfacs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NPC1 ABHD15 IL7R

8.07e-051812137286700396676fdc41d9723979b8b408177aceb9
ToppCellsystemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

NPC1 ABHD15 GSN

8.21e-051822139bbe8062aa562dc3b9c299581faf6ebbcb72a9f7
ToppCellsystemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

NPC1 ABHD15 GSN

8.21e-051822134602a98df7045e2c70b7560abfba9b444fbd5d30
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue

ABHD15 GSN IL7R

8.48e-05184213479e60f76c191253e23699c9dd7ef7efc08c59ad
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRICKLE2 TINAG INSR

8.75e-05186213f28d72b47624b69a580b4429e2be560a26898591
ToppCellSmart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ABHD15 GSN IL7R

8.75e-05186213855c2e5a8a6cf94c7de31982e0e2416f924439d3
ToppCelldroplet-Limb_Muscle-nan-3m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRICKLE2 ALG9 HID1

9.18e-0518921316a4c92dd7a0d60f3691bd3130a091a9a54730f1
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PRICKLE2 TINAG INSR

9.32e-05190213989d4eefd22d66ecb857836f8fdbcf41e3047f84
ToppCellCOVID-19_Moderate-pDC|COVID-19_Moderate / disease group, cell group and cell class

NPC1 ABHD15 GSN

9.47e-051912139d0ffa65c547e20b4076fd97776d7738cbd453ec
ToppCellILEUM-non-inflamed-(6)_ILC3|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

ABHD15 GSN IL7R

9.47e-051912136eaf72b41084404bee0db04e4605db745a74995f
ToppCell10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue

ABHD15 GSN IL7R

9.62e-05192213e16035b3328f9b1b2e28d234c62ba88387540550
ToppCellControl-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PRICKLE2 RUNDC3B IL7R

9.76e-05193213aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCellcontrol-pDC|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

NPC1 ABHD15 GSN

9.76e-0519321330a6559c9a9e8941861cb259b4836acccc427e68
ToppCellControl-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PRICKLE2 RUNDC3B IL7R

9.76e-05193213c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RUNDC3B GSN INSR

1.01e-041952136bdef651cf73d7381e5012d0eb3c809138fb6b92
ToppCellILEUM-inflamed-(6)_ILC3|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

ABHD15 GSN IL7R

1.01e-04195213c6968da7d2b60c2163e1ff0ffa41340e1ec1d2ed
ToppCell10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

RUNDC3B ALG9 INSR

1.02e-04196213ed818de15f84f7f28bd06fd69d7876710da232a0
ToppCelldistal-Endothelial-Bronchial_Vessel_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

RUNDC3B GSN INSR

1.04e-04197213f45a93b5ad80a16b760acbaa6467648ffc05a0d3
ToppCellMS-Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, condition lineage and cell class

NPC1 ABHD15 GSN

1.07e-04199213c10c8c9322cad4996e4aa11a8680e3d781644ace
ToppCellCOVID-19-COVID-19_Mild-Myeloid-pDC|COVID-19_Mild / Disease, condition lineage and cell class

NPC1 ABHD15 GSN

1.07e-041992139de61e5189d907cc969ac3043d68204f70acc0bf
ToppCellCaecum-ILC|Caecum / Region, Cell class and subclass

ABHD15 GSN IL7R

1.08e-04200213a9a1f03b4f415da860fb52eaedb07f0743692c98
ToppCell(3)_ILC|World / shred on Cell_type and subtype

ABHD15 GSN IL7R

1.08e-0420021303554b3f323785b1e0b48fa32de0d92065dd798e
ToppCellCaecum-ILC-ILC|Caecum / Region, Cell class and subclass

ABHD15 GSN IL7R

1.08e-042002133ac18c3ef335cb83d6a826f6c7519a5e7804929d
ToppCellTransverse-(3)_ILC-(30)_ILC|Transverse / shred on region, Cell_type, and subtype

ABHD15 GSN IL7R

1.08e-04200213528520dc98775aca6cc7568fedf5906ea55e0bea
ToppCellTransverse-(3)_ILC|Transverse / shred on region, Cell_type, and subtype

ABHD15 GSN IL7R

1.08e-04200213c1ad7cb012e1c8911e417f7d64ca662c4f5010e0
ToppCellTransverse-ILC|Transverse / Region, Cell class and subclass

ABHD15 GSN IL7R

1.08e-04200213eb04d6ad2270d3d9ac3d1fae1bb9bedc6fca38fe
ToppCellTransverse-ILC-ILC|Transverse / Region, Cell class and subclass

ABHD15 GSN IL7R

1.08e-0420021360ec185df2f1989bf8febf75b11c46a576829be3
ToppCellCaecum-(3)_ILC|Caecum / shred on region, Cell_type, and subtype

ABHD15 GSN IL7R

1.08e-042002136857863b3200162c250123688af2cba681afcb35
ToppCellCaecum-(3)_ILC-(30)_ILC|Caecum / shred on region, Cell_type, and subtype

ABHD15 GSN IL7R

1.08e-04200213ccd323997613b65f0189c0c66d76fbf273e18c03
ToppCell(30)_ILC|World / shred on Cell_type and subtype

ABHD15 GSN IL7R

1.15e-04204213bd9fbd278c05e396463704d711b60d47699e3c09
DiseaseCystic liver disease

ALG8 ALG9

4.82e-072212C4551631
DiseasePolycystic liver disease

ALG8 ALG9

4.82e-065212C0158683
DiseaseCystic Kidney Diseases

ALG8 ALG9

2.64e-0511212C1691228
Diseasecongenital disorder of glycosylation type I (implicated_via_orthology)

ALG8 ALG9

5.04e-0515212DOID:0050570 (implicated_via_orthology)
Diseasecardiovascular disease

NPC1 ALG9 INSR ABHD16B

2.76e-04457214EFO_0000319
DiseaseCongenital disorder of glycosylation

ALG8 ALG9

3.34e-0438212cv:C0282577
Diseasecarbohydrate measurement

TINAG GSN

4.90e-0446212EFO_0004998

Protein segments in the cluster

PeptideGeneStartEntry
EWYRFPSSFLLPDNW

ALG9

471

Q9H6U8
WFEAGLPWPYERGFL

ABHD15

271

Q6UXT9
SYTYPFRGWPVAFRW

ABHD16B

21

Q9H3Z7
YWPFGAFCDVWVAFD

DRD5

106

P21918
GDWFPIEYPDSWYRD

NAA60

31

Q9H7X0
FGDRPFWWVHESGYY

G6PC3

76

Q9BUM1
FVLEFRFEYLWPFWL

MACO1

46

Q8N5G2
FWSEWSPSYYFRTPE

IL7R

216

P16871
WEPYWPPDFRDLLGF

INSR

516

P06213
GFAPSSWIDDYFDWV

NPC1

936

O15118
FGDRWGPYFAEYDWC

PRICKLE2

761

Q7Z3G6
YPLTVDFEAFGWDWI

GDF11

316

O95390
FEPPSFVGWFLGWDD

GSN

751

P06396
WFGYESPRSFWDYIR

RUNDC3B

101

Q96NL0
PYIFEDPDWRGFFWS

HID1

106

Q8IV36
SEWTLDYPPFFAWFE

ALG8

61

Q9BVK2
CWADFGFPWGPRAYL

AVPR1B

186

P47901
AFFPVFSYKPWFTGW

TMEM212

26

A6NML5
DLPEFFVASYKWPGW

TINAG

216

Q9UJW2
LDIGGPWFPHYDFEW

USP6

461

P35125
PWWFADFPYPYAERL

GRIN2D

1131

O15399